Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ: EXAS )

50.48 +0.85 (+1.71%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences
BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares... 
Via Benzinga
As Cathie Wood's ARK ETF Surges, These 7 Stocks In The Fund Are Up Over 20% In 5 Days
Cathie Wood, the founder, CEO and CIO of ARK Investment Management, has had a tough year in the stock market as all eight of the company's exchange-traded funds (ETFs) were down substantially lower... 
Via Benzinga
Cathie Wood's ARK Innovation ETF Marks Record Surge On Thursday: Here's What She Offloaded Amid Market Rally
Cathie Wood-owned ARK Investment Management’s flagship fund, the ARK Innovation ETF (NYSE: ARKK) close 
Via Benzinga
Expert Ratings for Exact Sciences
Over the past 3 months, 4 analysts have published their opinion on Exact Sciences (NASDAQ:EXAS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Where Exact Sciences Stands With Analysts
Exact Sciences (NASDAQ:EXAS) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Why Exact Sciences Stock Is Soaring Today
Investors are reacting positively to the company's Q3 update. 
Via The Motley Fool
Exact Sciences (EXAS) Q3 2022 Earnings Call Transcript
EXAS earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Raymond James Maintains Outperform Rating for Exact Sciences: Here's What You Need To Know
Raymond James has decided to maintain its Outperform rating of Exact Sciences (NASDAQ:EXAS) and lower its price target from $70.00 to $60.00. Shares of Exact Sciences are trading up 3.28% over the last... 
Via Benzinga
SolarEdge To Rally 54%? Plus This Analyst Predicts $1,335 For Mettler-Toledo International
Goldman Sachs raised the price target on Mettler-Toledo International Inc. (NYSE: MTD) from $1,120 to $1,335. Goldman Sachs analyst Matthew Sykes upgraded the stock from Sell to Neutral. Mettler-Toledo... 
Via Benzinga
Apple To $154? Plus This Analyst Predicts $2,650 For Booking Holdings
B of A Securities cut the price target on Apple Inc. (NASDAQ: AAPL) from $160 to $154. Apple shares fell 1.5% to trade at $136.34 on Monday 
Via Benzinga
5 Top Stocks Cathie Wood Is Buying This Week
Cathie Wood just lauded Elon Musk's acquisition of Twitter, believing the platform will become a "super-app." Here are her top five buys. 
Via InvestorPlace
Block, MasTec, Universal Display And Some Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Recap: Exact Sciences Q3 Earnings
Exact Sciences (NASDAQ:EXAS) reported its Q3 earnings results on Thursday, November 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Gainers 
Via Benzinga
Exact Sciences Boosts 2022 Outlook After Crushing Third-Quarter Forecasts
Exact Sciences boosted its 2022 guidance by $33 million after a strong quarter. 
Via Investor's Business Daily
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
8 Analysts Have This to Say About Exact Sciences
Analysts have provided the following ratings for Exact Sciences (NASDAQ:EXAS) within the last quarter: 
Via Benzinga
2 Stocks That Could Double in the Next 5 Years
These companies aren't handling the downturn well, but they can turn things around. 
Via The Motley Fool
Cathie Wood's Funds Deliver Mixed Q3 Results: Ark Founder's Shares Take On Zoom, Roku, Teladoc And Blockchain
Cathie Wood-led ARK Investment Management’s flagship fund ARK Innovation ETF’s (NYSE: ARKK) performance during the third quarter was mixed relative to broad-based indexes, as it outperformed the MSCI... 
Via Benzinga
What 8 Analyst Ratings Have To Say About Exact Sciences
Over the past 3 months, 8 analysts have published their opinion on Exact Sciences (NASDAQ:EXAS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Why Guardant Health Stock Fell 5.5% Today
Is Guardant Health as obvious a bargain as this analyst makes it out to be? 
Via The Motley Fool
Amazon, Bank of America, Microsoft And Other Big Gainers From Monday
U.S. stocks closed higher on Monday, with the Dow Jones gaining around 550 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
Upgrades 
Via Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case. 
Via Benzinga
3 Growth Stocks That Could Double Your Money, According to Wall Street
Investment bank analysts think these stocks will shoot through the roof once the rest of the market sees them in the same light. 
Via The Motley Fool
3 Cathie Wood Stocks That Are Too Cheap to Ignore
These Cathie Wood stocks are risky, but offer immense upside potential down the road, for those willing to take a more aggressive approach. 
Via InvestorPlace
Is Illumina Still the Gamechanger in Genomics Sequencing?
Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused 
Via MarketBeat
Topics Earnings Economy Lawsuit
Exposures Financial Legal Supply Chain
7 Cheap Cathie Wood Stocks to Buy in October
Ark launched a new fund on Sept. 27. While you try to figure it out, here are 7 cheap Cathie Wood stocks to buy for October. 
Via InvestorPlace
Mainz Biomed (MYNZ) nominates two notable leaders in key areas of the diagnostics field to its Board of Directors
Via AB Newswire
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS